Metallodrugs in cancer nanomedicineQuim Peña, Twan Lammers, Alec Wang et al.|Chemical Society Reviews|2022Cited by 245
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responsesLászló Dézsi, János Szebeni, Tamás Fülöp et al.|Journal of Controlled Release|2014Cited by 99
Monitoring EPR Effect Dynamics during Nanotaxane Treatment with Theranostic Polymeric MicellesIlaria Biancacci, Twan Lammers, Wim E. Hennink et al.|Advanced Science|2022Cited by 65
Docosahexaenoic acid liposomes for targeting chronic inflammatory diseases and cancer: an in vitro assessmentAmr Alaarg, Robbert J. Kok, Nan Yeun Jordan et al.|International Journal of Nanomedicine|2016Cited by 59
Ultrasound-directed enzyme-prodrug therapy (UDEPT) using self-immolative doxorubicin derivativesKarolin Roemhild, Twan Lammers, Helena C. Besse et al.|Theranostics|2022Cited by 18